Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹2,101 Cr revenue.
COGS 53.9%, employees 4.1%.
“we are on track to achieve our visionary Chairman's vision of INR 5,000 crores of revenue and INR 1,000 crores of EBITDA over the next three to four years, representing a growth of more than 2x.”
“we will endeavor to work in maintaining the EBITDA margin between 24% to 26%.”
“the initial capacity of 6,000 should be up and running by December.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 23.7%▲ | 7.6% |
| ROCE | 26.9%▲ | 10.9% |
| Net Margin | 11.8%▲ | 5.1% |
| EBITDA Margin | 25.3%▲ | 12.1% |
| Debt To Equity | 0.85x▲ | 0.20x |
| Rev Growth 3yr | 13.9%▲ | 5.9% |
| EPS Growth 3yr | 23.8%▲ | -9.4% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,456 Cr +16.9% | ₹2,101 Cr +19.9% | ₹1,752 Cr +9.0% | ₹1,608 Cr +14.5% | ₹1,404 Cr +10.0% | ₹1,277 Cr -21.7% | ₹1,631 Cr +21.6% | ₹1,341 Cr |
| Other Income | ₹30 Cr +47.3% | ₹21 Cr -21.5% | ₹26 Cr +22.8% | ₹21 Cr -33.9% | ₹32 Cr +62.3% | ₹20 Cr -25.2% | ₹27 Cr +368.3% | ₹6 Cr |
| Total Income | ₹2,486 Cr +17.2% | ₹2,122 Cr +19.3% | ₹1,779 Cr +9.2% | ₹1,629 Cr +13.4% | ₹1,436 Cr +10.8% | ₹1,297 Cr -21.8% | ₹1,657 Cr +23.1% | ₹1,347 Cr |
| COGS | ₹1,252 Cr +10.6% | ₹1,131 Cr +12.1% | ₹1,009 Cr +5.0% | ₹961 Cr +15.6% | ₹831 Cr +10.6% | ₹751 Cr -25.5% | ₹1,008 Cr +21.9% | ₹827 Cr |
| ₹2,086 Cr +11.7% | ₹1,867 Cr +13.3% | ₹1,649 Cr +3.2% | ₹1,598 Cr +22.1% | ₹1,309 Cr +12.7% | ₹1,161 Cr -20.8% | ₹1,466 Cr +21.7% | ₹1,204 Cr | |
| Profit Before Tax | ₹400 Cr +57.1% | ₹255 Cr +95.9% | ₹130 Cr +318.5% | ₹31 Cr -76.6% | ₹133 Cr -16.1% | ₹158 Cr -31.6% | ₹231 Cr +52.6% | ₹152 Cr |
| ₹113 Cr +62.5% | ₹70 Cr +102.4% | ₹34 Cr +253.1% | ₹10 Cr -72.4% | ₹35 Cr -14.4% | ₹41 Cr -24.8% | ₹55 Cr -4.1% | ₹57 Cr | |
| Net Profit | ₹287 Cr +55.1% | ₹185 Cr +93.6% | ₹95 Cr +348.5% | ₹21 Cr -78.1% | ₹97 Cr -16.7% | ₹117 Cr -33.7% | ₹176 Cr +87.1% | ₹94 Cr |
| Profit (Owners) | ₹294 Cr +59.2% | ₹185 Cr +93.6% | ₹95 Cr +329.6% | ₹22 Cr -77.2% | ₹97 Cr -16.7% | ₹117 Cr -33.7% | ₹176 Cr +87.1% | ₹94 Cr |
| Minority Interest | (₹8 Cr) | ₹0.00 Cr | ₹0.00 Cr +100.0% | (₹0.94 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Other Comprehensive Income | (₹0.96 Cr) -571.7% | (₹0.14 Cr) ↓ Decline | ₹0.41 Cr -82.8% | ₹2 Cr | ₹0.18 Cr ↑ Recovery | (₹0.58 Cr) ↓ Decline | ₹0.53 Cr ↑ Recovery | (₹0.16 Cr) |
| EPS | ₹75.29 | ₹47.30 | ₹24.43 | ₹5.69 | ₹24.93 | ₹29.93 | ₹45.14 | ₹24.13 |
| Diluted Shares | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Bhaktavatsala Doppalapudi Rao has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ...
Privi Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeov...
Privi Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeov...
Privi Speciality Chemicals Limited has informed the Exchange about Schedule of meet
Privi Speciality Chemicals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeov...
Bhaktavatsala Doppalapudi Rao has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ...
Mahesh Purshottam Babani has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regul...
Privi Speciality Chemicals Limited has informed the Exchange about Schedule of meet
Privi Speciality Chemicals Limited has informed the Exchange about Transcript
Privi Speciality Chemicals Limited has informed the Exchange about General Updates
Privi Speciality Chemicals Limited has informed the Exchange that Record date for the purpose of Dividend is 31-Jul-2026.
Privi Speciality Chemicals Limited has informed the Exchange regarding Change in Auditors of the company.
Privi Speciality Chemicals Limited has informed the Exchange regarding Change in Director(s) of the company.
Privi Speciality Chemicals Limited has informed the Exchange that Board of Directors at its meeting held on May 11, 2026, recommended Final Dividend of Rs. 10 per equity share.
Privi Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.